Lynparza approved in the EU for the treatment of BRCA- mutated metastatic castration-resistant prostate cancer Read more
TFF Pharmaceuticals and Felix Biotechnology Sign Letter of Intent for a Collaboration, Development and License Agreement Read more
Isotopia Molecular Imaging begins clinical supply collaboration with Y-mAbs Therapeutics, Inc. Read more
NanOlogy Enrolls First Patient in Phase 2 Clinical Trial of NanoPac for Intratumoral Treatment of Prostate Cancer Read more
Axsome Therapeutics and Veeva Systems Partner to Build Axsome’s Digital-Centric Commercialization Platform Read more
XNK Therapeutics receives US orphan drug status for NK cell-based immunotherapy in multiple myeloma Read more